{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:20:09Z","timestamp":1788412809964,"version":"build-2803163510"},"reference-count":118,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The intrinsic tenase (Xase) complex, formed by factors (f) VIIIa and fIXa, forms on activated platelet surfaces and catalyzes the activation of factor X to Xa, stimulating thrombin production in the blood coagulation cascade. The structural organization of the membrane-bound Xase complex remains largely unknown, hindering our understanding of the structural underpinnings that guide Xase complex assembly. Here, we aimed to characterize the Xase complex bound to a lipid nanodisc with biolayer interferometry (BLI), Michaelis\u2013Menten kinetics, and small-angle X-ray scattering (SAXS). Using immobilized lipid nanodiscs, we measured binding rates and nanomolar affinities for fVIIIa, fIXa, and the Xase complex. Enzyme kinetic measurements demonstrated the assembly of an active enzyme complex in the presence of lipid nanodiscs. An ab initio molecular envelope of the nanodisc-bound Xase complex allowed us to computationally model fVIIIa and fIXa docked onto a flexible lipid membrane and identify protein\u2013protein interactions. Our results highlight multiple points of contact between fVIIIa and fIXa, including a novel interaction with fIXa at the fVIIIa A1\u2013A3 domain interface. Lastly, we identified hemophilia A\/B-related mutations with varying severities at the fVIIIa\/fIXa interface that may regulate Xase complex assembly. Together, our results support the use of SAXS as an emergent tool to investigate the membrane-bound Xase complex and illustrate how mutations at the fVIIIa\/fIXa dimer interface may disrupt or stabilize the activated enzyme complex.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005874","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T19:39:03Z","timestamp":1646681943000},"page":"3240-3254","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa\/IXa"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0472-7859","authenticated-orcid":false,"given":"Kenneth C.","family":"Childers","sequence":"first","affiliation":[{"name":"1Department of Chemistry, Western Washington University, Bellingham, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-9685","authenticated-orcid":false,"given":"Shaun C.","family":"Peters","sequence":"additional","affiliation":[{"name":"1Department of Chemistry, Western Washington University, Bellingham, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-8104","authenticated-orcid":false,"given":"Pete","family":"Lollar","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold Trent","family":"Spencer","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5662-0060","authenticated-orcid":false,"given":"Christopher B.","family":"Doering","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Paul C.","family":"Spiegel","sequence":"additional","affiliation":[{"name":"1Department of Chemistry, Western Washington University, Bellingham, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"2","key":"2022053115234683600_B1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1532\/IJH97.05113","article-title":"Factor VIII structure and function","volume":"83","author":"Fay","year":"2006","journal-title":"Int J Hematol."},{"key":"2022053115234683600_B2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.blre.2019.03.002","article-title":"Factor VIII: long-established role in haemophilia A and emerging evidence beyond haemostasis","volume":"35","author":"Samuelson Bannow","year":"2019","journal-title":"Blood Rev."},{"issue":"1","key":"2022053115234683600_B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0268-960X(03)00025-0","article-title":"Activation of factor VIII and mechanisms of cofactor action","volume":"18","author":"Fay","year":"2004","journal-title":"Blood Rev."},{"issue":"29","key":"2022053115234683600_B4","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1074\/jbc.272.29.18007","article-title":"The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor","volume":"272","author":"Saenko","year":"1997","journal-title":"J Biol Chem."},{"issue":"37","key":"2022053115234683600_B5","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1021\/bi00088a009","article-title":"Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine","volume":"32","author":"Gilbert","year":"1993","journal-title":"Biochemistry."},{"issue":"39","key":"2022053115234683600_B6","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1021\/acs.biochem.5b00417","article-title":"Membrane interaction of the factor VIIIa discoidin domains in atomistic detail","volume":"54","author":"Madsen","year":"2015","journal-title":"Biochemistry."},{"issue":"3","key":"2022053115234683600_B7","doi-asserted-by":"crossref","first-page":"e0122447","DOI":"10.1371\/journal.pone.0122447","article-title":"The 1.7 \u00c5 X-ray crystal structure of the porcine factor VIII C2 domain and binding analysis to anti-human C2 domain antibodies and phospholipid surfaces","volume":"10","author":"Brison","year":"2015","journal-title":"PLoS One."},{"issue":"9","key":"2022053115234683600_B8","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2012-01-408245","article-title":"Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity","volume":"120","author":"Gilbert","year":"2012","journal-title":"Blood."},{"issue":"3","key":"2022053115234683600_B9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/BJ20140121","article-title":"Changes in the factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS","volume":"461","author":"Pantazatos","year":"2014","journal-title":"Biochem J."},{"issue":"21","key":"2022053115234683600_B10","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1073\/pnas.92.21.9796","article-title":"X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B","volume":"92","author":"Brandstetter","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"issue":"38","key":"2022053115234683600_B11","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1021\/bi00038a005","article-title":"Structure of the calcium ion-bound \u03b3-carboxyglutamic acid-rich domain of factor IX","volume":"34","author":"Freedman","year":"1995","journal-title":"Biochemistry."},{"issue":"10","key":"2022053115234683600_B12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/jth.13788","article-title":"Lipid specificity of the membrane binding domain of coagulation factor X","volume":"15","author":"Muller","year":"2017","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022053115234683600_B13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jth.14401","article-title":"Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study","volume":"17","author":"Vadivel","year":"2019","journal-title":"J Thromb Haemost."},{"issue":"3","key":"2022053115234683600_B14","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0021-9258(19)40071-9","article-title":"pH-dependent denaturation of thrombin-activated porcine factor VIII","volume":"265","author":"Lollar","year":"1990","journal-title":"J Biol Chem."},{"issue":"11","key":"2022053115234683600_B15","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.271.11.6027","article-title":"Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis","volume":"271","author":"Fay","year":"1996","journal-title":"J Biol Chem."},{"issue":"8","key":"2022053115234683600_B16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0969-2126(99)80125-7","article-title":"Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding","volume":"7","author":"Hopfner","year":"1999","journal-title":"Structure."},{"issue":"12","key":"2022053115234683600_B17","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.str.2009.10.011","article-title":"Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa","volume":"17","author":"Z\u00f6gg","year":"2009","journal-title":"Structure."},{"issue":"6","key":"2022053115234683600_B18","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1074\/jbc.M210722200","article-title":"Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop","volume":"278","author":"Sichler","year":"2003","journal-title":"J Biol Chem."},{"issue":"10","key":"2022053115234683600_B19","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/bi00462a025","article-title":"Kinetics of coagulation factor X activation by platelet-bound factor IXa","volume":"29","author":"Rawala-Sheikh","year":"1990","journal-title":"Biochemistry."},{"issue":"19","key":"2022053115234683600_B20","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1074\/jbc.271.19.11120","article-title":"Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine","volume":"271","author":"Gilbert","year":"1996","journal-title":"J Biol Chem."},{"issue":"7","key":"2022053115234683600_B21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jth.12958","article-title":"Hemophilia\u00a0B: molecular pathogenesis and mutation analysis","volume":"13","author":"Goodeve","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"17","key":"2022053115234683600_B22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","article-title":"X-linked thrombophilia with a mutant factor IX (factor IX Padua)","volume":"361","author":"Simioni","year":"2009","journal-title":"N Engl J Med."},{"issue":"1","key":"2022053115234683600_B23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3324\/haematol.2019.216713","article-title":"Factor IX alteration p.Arg338Gln (FIX Shanghai) potentiates FIX clotting activity and causes thrombosis","volume":"106","author":"Wu","year":"2021","journal-title":"Haematologica."},{"issue":"5","key":"2022053115234683600_B24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/bloodadvances.2019000405","article-title":"Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants","volume":"5","author":"Samelson-Jones","year":"2021","journal-title":"Blood Adv."},{"issue":"4","key":"2022053115234683600_B25","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1055\/s-0039-1698414","article-title":"Venous thrombosis in acquired hemophilia: the complex management of competing pathologies","volume":"3","author":"Chhabra","year":"2019","journal-title":"TH Open."},{"issue":"4","key":"2022053115234683600_B26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.0000260470.02821.fe","article-title":"Emerging anticoagulant drugs","volume":"27","author":"Weitz","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"10","key":"2022053115234683600_B27","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1055\/s-0038-1669785","article-title":"The first intrinsic tenase complex inhibitor with serine protease structure offers a new perspective in anticoagulant therapy","volume":"118","author":"Latinovi\u0107","year":"2018","journal-title":"Thromb Haemost."},{"issue":"27","key":"2022053115234683600_B28","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1073\/pnas.1504229112","article-title":"Discovery of an intrinsic tenase complex inhibitor: pure nonasaccharide from fucosylated glycosaminoglycan","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"issue":"10","key":"2022053115234683600_B29","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1016\/S0021-9258(17)37260-5","article-title":"Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII","volume":"269","author":"Lenting","year":"1994","journal-title":"J Biol Chem."},{"issue":"32","key":"2022053115234683600_B30","doi-asserted-by":"crossref","first-page":"20522","DOI":"10.1016\/S0021-9258(17)32024-0","article-title":"Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site","volume":"269","author":"Fay","year":"1994","journal-title":"J Biol Chem."},{"issue":"19","key":"2022053115234683600_B31","doi-asserted-by":"crossref","first-page":"16302","DOI":"10.1074\/jbc.M011680200","article-title":"Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa","volume":"276","author":"Bajaj","year":"2001","journal-title":"J Biol Chem."},{"issue":"33","key":"2022053115234683600_B32","doi-asserted-by":"crossref","first-page":"31297","DOI":"10.1074\/jbc.M302840200","article-title":"The Gla domain of factor IXa binds to factor VIIIa in the tenase complex","volume":"278","author":"Blostein","year":"2003","journal-title":"J Biol Chem."},{"issue":"6","key":"2022053115234683600_B33","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1074\/jbc.M804955200","article-title":"The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex","volume":"284","author":"Soeda","year":"2009","journal-title":"J Biol Chem."},{"issue":"21","key":"2022053115234683600_B34","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1074\/jbc.M113.456467","article-title":"Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa","volume":"288","author":"Griffiths","year":"2013","journal-title":"J Biol Chem."},{"issue":"30","key":"2022053115234683600_B35","doi-asserted-by":"crossref","first-page":"19049","DOI":"10.1074\/jbc.273.30.19049","article-title":"The A2 subunit of factor VIIIa modulates the active site of factor IXa","volume":"273","author":"Fay","year":"1998","journal-title":"J Biol Chem."},{"issue":"23","key":"2022053115234683600_B36","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood.2020005593","article-title":"Factor VIII-driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry","volume":"136","author":"Freato","year":"2020","journal-title":"Blood."},{"issue":"6","key":"2022053115234683600_B37","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/jth.15288","article-title":"Probing activation-driven changes in coagulation factor IX by mass spectrometry","volume":"19","author":"Freato","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022053115234683600_B38","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1074\/jbc.271.4.1935","article-title":"The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX","volume":"271","author":"Lenting","year":"1996","journal-title":"J Biol Chem."},{"issue":"16","key":"2022053115234683600_B39","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2013-06-511733","article-title":"Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis","volume":"122","author":"Lechtenberg","year":"2013","journal-title":"Blood."},{"issue":"9","key":"2022053115234683600_B40","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1538-7836.2005.01527.x","article-title":"Molecular models of the procoagulant factor VIIIa-factor IXa complex","volume":"3","author":"Autin","year":"2005","journal-title":"J Thromb Haemost."},{"issue":"3","key":"2022053115234683600_B41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbrc.2014.08.078","article-title":"Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study","volume":"452","author":"Venkateswarlu","year":"2014","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"2022053115234683600_B42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.str.2008.03.001","article-title":"Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex","volume":"16","author":"Ngo","year":"2008","journal-title":"Structure."},{"issue":"8","key":"2022053115234683600_B43","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1074\/jbc.M312451200","article-title":"Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion","volume":"279","author":"Doering","year":"2004","journal-title":"J Biol Chem."},{"issue":"20","key":"2022053115234683600_B44","doi-asserted-by":"crossref","first-page":"13922","DOI":"10.1074\/jbc.M513124200","article-title":"A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation","volume":"281","author":"Parker","year":"2006","journal-title":"J Biol Chem."},{"issue":"11","key":"2022053115234683600_B45","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/ja0393574","article-title":"Directed self-assembly of monodisperse phospholipid bilayer nanodiscs with controlled size","volume":"126","author":"Denisov","year":"2004","journal-title":"J Am Chem Soc."},{"issue":"66","key":"2022053115234683600_B46","first-page":"e3910","article-title":"A step-by-step method for the reconstitution of an ABC transporter into nanodisc lipid particles","author":"Bao","year":"2012","journal-title":"J Vis Exp."},{"issue":"1","key":"2022053115234683600_B47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nprot.2017.094","article-title":"Assembly of phospholipid nanodiscs of controlled size for structural studies of membrane proteins by NMR","volume":"13","author":"Hagn","year":"2018","journal-title":"Nat Protoc."},{"issue":"1","key":"2022053115234683600_B48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/ntrev-2016-0073","article-title":"Reversible stacking of lipid nanodiscs for structural studies of clotting factors","volume":"6","author":"Grushin","year":"2017","journal-title":"Nanotechnol Rev."},{"issue":"11","key":"2022053115234683600_B49","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/protein\/gzq060","article-title":"Engineering extended membrane scaffold proteins for self-assembly of soluble nanoscale lipid bilayers","volume":"23","author":"Grinkova","year":"2010","journal-title":"Protein Eng Des Sel."},{"issue":"84","key":"2022053115234683600_B50","first-page":"e51383","article-title":"Bio-layer interferometry for measuring kinetics of protein-protein interactions and allosteric ligand effects","volume":"84","author":"Shah","year":"2014","journal-title":"J Vis Exp."},{"issue":"9","key":"2022053115234683600_B51","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1073\/pnas.91.9.3574","article-title":"First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa\/tissue factor but not by factor XIa","volume":"91","author":"Zhong","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"issue":"45","key":"2022053115234683600_B52","doi-asserted-by":"crossref","first-page":"46400","DOI":"10.1074\/jbc.M406552200","article-title":"Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets","volume":"279","author":"Yang","year":"2004","journal-title":"J Biol Chem."},{"issue":"10","key":"2022053115234683600_B53","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.chembiol.2004.08.006","article-title":"Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII","volume":"11","author":"Spiegel","year":"2004","journal-title":"Chem Biol."},{"issue":"Pt 3","key":"2022053115234683600_B54","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1107\/S1600576716005136","article-title":"Quantifying radiation damage in biomolecular small-angle X-ray scattering","volume":"49","author":"Hopkins","year":"2016","journal-title":"J Appl Cryst."},{"issue":"5","key":"2022053115234683600_B55","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1107\/S0021889803012779","article-title":"PRIMUS: a Windows PC-based system for small-angle scattering data analysis","volume":"36","author":"Konarev","year":"2003","journal-title":"J Appl Cryst."},{"issue":"pt 4","key":"2022053115234683600_B56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1107\/S0021889892001663","article-title":"Determination of the regularization parameter in indirect-transform methods using perceptual criteria","volume":"25","author":"Svergun","year":"1992","journal-title":"J Appl Cryst."},{"issue":"6","key":"2022053115234683600_B57","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/S0006-3495(99)77443-6","article-title":"Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing","volume":"76","author":"Svergun","year":"1999","journal-title":"Biophys J."},{"issue":"3","key":"2022053115234683600_B58","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1107\/S0021889803000268","article-title":"Uniqueness of ab initio shape determination in small-angle scattering","volume":"36","author":"Volkov","year":"2003","journal-title":"J Appl Cryst."},{"issue":"2","key":"2022053115234683600_B59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.str.2018.10.008","article-title":"MT1-MMP binds membranes by opposite tips of Its \u03b2 propeller to position it for pericellular proteolysis","volume":"27","author":"Marcink","year":"2019","journal-title":"Structure."},{"issue":"2","key":"2022053115234683600_B60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nsmb.3345","article-title":"Solution structure of discoidal high-density lipoprotein particles with a shortened apolipoprotein A-I","volume":"24","author":"Bibow","year":"2017","journal-title":"Nat Struct Mol Biol."},{"issue":"8","key":"2022053115234683600_B61","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1039\/C5CP04540A","article-title":"Deciphering conformational transitions of proteins by small angle X-ray scattering and normal mode analysis","volume":"18","author":"Panjkovich","year":"2016","journal-title":"Phys Chem Chem Phys."},{"issue":"W1","key":"2022053115234683600_B62","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2022053115234683600_B63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.14621","article-title":"The 3.2 \u00c5 structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain","volume":"18","author":"Smith","year":"2020","journal-title":"J Thromb Haemost."},{"key":"2022053115234683600_B64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/nar\/gkn216","article-title":"The RosettaDock server for local protein-protein docking","volume":"36","author":"Lyskov","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"2022053115234683600_B65","doi-asserted-by":"crossref","first-page":"e22477","DOI":"10.1371\/journal.pone.0022477","article-title":"Benchmarking and analysis of protein docking performance in Rosetta v3.2","volume":"6","author":"Chaudhury","year":"2011","journal-title":"PLoS One."},{"issue":"5","key":"2022053115234683600_B66","doi-asserted-by":"crossref","first-page":"e63906","DOI":"10.1371\/journal.pone.0063906","article-title":"Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE)","volume":"8","author":"Lyskov","year":"2013","journal-title":"PLoS One."},{"issue":"W1","key":"2022053115234683600_B67","doi-asserted-by":"crossref","first-page":"W424","DOI":"10.1093\/nar\/gkw389","article-title":"FoXS, FoXSDock and MultiFoXS: Single-state and multi-state structural modeling of proteins and their complexes based on SAXS profiles","volume":"44","author":"Schneidman-Duhovny","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"2022053115234683600_B68","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.bpj.2013.07.020","article-title":"Accurate SAXS profile computation and its assessment by contrast variation experiments","volume":"105","author":"Schneidman-Duhovny","year":"2013","journal-title":"Biophys J."},{"key":"2022053115234683600_B69","doi-asserted-by":"crossref","first-page":"e56518","DOI":"10.7554\/eLife.56518","article-title":"Structure and dynamics of a nanodisc by integrating NMR, SAXS and SANS experiments with molecular dynamics simulations","volume":"9","author":"Bengtsen","year":"2020","journal-title":"eLife."},{"issue":"39","key":"2022053115234683600_B70","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.1021\/ja1030613","article-title":"Elliptical structure of phospholipid bilayer nanodiscs encapsulated by scaffold proteins: casting the roles of the lipids and the protein","volume":"132","author":"Skar-Gislinge","year":"2010","journal-title":"J Am Chem Soc."},{"issue":"Pt 12","key":"2022053115234683600_B71","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1107\/S1399004715018702","article-title":"Small-angle scattering determination of the shape and localization of human cytochrome P450 embedded in a phospholipid nanodisc environment","volume":"71","author":"Skar-Gislinge","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"issue":"32","key":"2022053115234683600_B72","doi-asserted-by":"crossref","first-page":"15580","DOI":"10.1021\/jp051385g","article-title":"Thermotropic phase transition in soluble nanoscale lipid bilayers","volume":"109","author":"Denisov","year":"2005","journal-title":"J Phys Chem B."},{"issue":"Pt 1","key":"2022053115234683600_B73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1107\/S1600576717018441","article-title":"Interpretation of solution scattering data from lipid nanodiscs","volume":"51","author":"Graziano","year":"2018","journal-title":"J Appl Cryst."},{"issue":"5","key":"2022053115234683600_B74","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1055\/s-0037-1613463","article-title":"The preparation and phospholipid binding property of the C2 domain of human factor VIII","volume":"89","author":"Takeshima","year":"2003","journal-title":"Thromb Haemost."},{"issue":"35","key":"2022053115234683600_B75","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1021\/bi060451h","article-title":"The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation","volume":"45","author":"Fribourg","year":"2006","journal-title":"Biochemistry."},{"issue":"43","key":"2022053115234683600_B76","doi-asserted-by":"crossref","first-page":"27918","DOI":"10.1074\/jbc.273.43.27918","article-title":"Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets","volume":"273","author":"Saenko","year":"1998","journal-title":"J Biol Chem."},{"issue":"8","key":"2022053115234683600_B77","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1074\/jbc.M107753200","article-title":"The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex","volume":"277","author":"Wilkinson","year":"2002","journal-title":"J Biol Chem."},{"issue":"12","key":"2022053115234683600_B78","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1016\/S0021-9258(18)42481-7","article-title":"The role of the first growth factor domain of human factor IXa in binding to platelets and in factor X activation","volume":"267","author":"Ahmad","year":"1992","journal-title":"J Biol Chem."},{"issue":"2","key":"2022053115234683600_B79","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0021-9258(19)40122-1","article-title":"Binding of human factor VIII to phospholipid vesicles","volume":"265","author":"Gilbert","year":"1990","journal-title":"J Biol Chem."},{"issue":"17","key":"2022053115234683600_B80","doi-asserted-by":"crossref","first-page":"13071","DOI":"10.1074\/jbc.275.17.13071","article-title":"Structural and functional characterization of platelet receptor-mediated factor VIII binding","volume":"275","author":"Ahmad","year":"2000","journal-title":"J Biol Chem."},{"issue":"1","key":"2022053115234683600_B81","doi-asserted-by":"crossref","first-page":"17407","DOI":"10.1038\/s41598-020-73647-3","article-title":"Phosphatidylethanolamine-phosphatidylserine binding synergy of seven coagulation factors revealed using Nanodisc arrays on silicon photonic sensors","volume":"10","author":"Medfisch","year":"2020","journal-title":"Sci Rep."},{"issue":"4","key":"2022053115234683600_B82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1160\/TH14-09-0725","article-title":"Factor VIII organisation on nanodiscs with different lipid composition","volume":"113","author":"Grushin","year":"2015","journal-title":"Thromb Haemost."},{"issue":"43","key":"2022053115234683600_B83","doi-asserted-by":"crossref","first-page":"26796","DOI":"10.1016\/S0021-9258(18)47089-5","article-title":"Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator","volume":"269","author":"Barrow","year":"1994","journal-title":"J Biol Chem."},{"issue":"17","key":"2022053115234683600_B84","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/bi036289p","article-title":"Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase","volume":"43","author":"Jenkins","year":"2004","journal-title":"Biochemistry."},{"issue":"1","key":"2022053115234683600_B85","doi-asserted-by":"crossref","first-page":"11212","DOI":"10.1038\/srep11212","article-title":"Dimeric organization of blood coagulation factor VIII bound to lipid nanotubes","volume":"5","author":"Dalm","year":"2015","journal-title":"Sci Rep."},{"issue":"24","key":"2022053115234683600_B86","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1016\/S0021-9258(18)41886-8","article-title":"The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study","volume":"267","author":"Mutucumarana","year":"1992","journal-title":"J Biol Chem."},{"issue":"5","key":"2022053115234683600_B87","first-page":"620","article-title":"Evaluation of a potential redox switch in blood coagulation tenase","volume":"8","author":"Cook","year":"2019","journal-title":"Biorxiv."},{"key":"2022053115234683600_B88","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood-2018-99-113260","article-title":"Contribution of factor VIII A3 domain residues 1793-1795 to a Factor IXa-interactive site","volume":"132","author":"Takeyama","year":"2018","journal-title":"Blood."},{"issue":"36","key":"2022053115234683600_B89","doi-asserted-by":"crossref","first-page":"26105","DOI":"10.1074\/jbc.M113.500884","article-title":"A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX","volume":"288","author":"Bloem","year":"2013","journal-title":"J Biol Chem."},{"issue":"41","key":"2022053115234683600_B90","doi-asserted-by":"crossref","first-page":"38345","DOI":"10.1074\/jbc.M206959200","article-title":"High level expression of recombinant porcine coagulation factor VIII","volume":"277","author":"Doering","year":"2002","journal-title":"J Biol Chem."},{"issue":"43","key":"2022053115234683600_B91","doi-asserted-by":"crossref","first-page":"31289","DOI":"10.1074\/jbc.M113.497289","article-title":"Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa","volume":"288","author":"Wakabayashi","year":"2013","journal-title":"J Biol Chem."},{"issue":"4","key":"2022053115234683600_B92","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1182\/blood.V99.4.1215","article-title":"3-dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography","volume":"99","author":"Stoilova-McPhie","year":"2002","journal-title":"Blood."},{"issue":"7","key":"2022053115234683600_B93","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/bip.22199","article-title":"Domain organization of membrane-bound factor VIII","volume":"99","author":"Stoilova-McPhie","year":"2013","journal-title":"Biopolymers."},{"issue":"1","key":"2022053115234683600_B94","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1074\/jbc.273.1.222","article-title":"Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain","volume":"273","author":"Christophe","year":"1998","journal-title":"J Biol Chem."},{"issue":"8","key":"2022053115234683600_B95","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1074\/jbc.M111.308627","article-title":"Mass spectrometry-assisted study reveals that lysine residues 1967 and 1968 have opposite contribution to stability of activated factor VIII","volume":"287","author":"Bloem","year":"2012","journal-title":"J Biol Chem."},{"issue":"23","key":"2022053115234683600_B96","doi-asserted-by":"crossref","first-page":"20214","DOI":"10.1074\/jbc.M108446200","article-title":"The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 domain","volume":"277","author":"Celie","year":"2002","journal-title":"J Biol Chem."},{"issue":"10","key":"2022053115234683600_B97","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00249-012-0820-x","article-title":"Validation of macromolecular flexibility in solution by small-angle X-ray scattering (SAXS)","volume":"41","author":"Hammel","year":"2012","journal-title":"Eur Biophys J."},{"issue":"6","key":"2022053115234683600_B98","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/S0021-9258(19)50585-3","article-title":"Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1\/A3-C1-C2 dimer","volume":"267","author":"Lamphear","year":"1992","journal-title":"J Biol Chem."},{"issue":"2","key":"2022053115234683600_B99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/BJ20130025","article-title":"Molecular orientation of factor VIIIa on the phospholipid membrane surface determined by fluorescence resonance energy transfer","volume":"452","author":"Wakabayashi","year":"2013","journal-title":"Biochem J."},{"key":"2022053115234683600_B100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bpc.2019.03.001","article-title":"Single-molecule measurement and bioinformatics analysis suggest a preferred orientation of human coagulation factor VIII on hydrophobic interfaces","volume":"248","author":"Cheng","year":"2019","journal-title":"Biophys Chem."},{"issue":"21","key":"2022053115234683600_B101","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood.2020008940","article-title":"Structure of blood coagulation factor VIII in complex with an anti-C1 domain pathogenic antibody inhibitor","volume":"137","author":"Gish","year":"2021","journal-title":"Blood."},{"issue":"21","key":"2022053115234683600_B102","doi-asserted-by":"crossref","first-page":"697602","DOI":"10.3389\/fimmu.2021.697602","article-title":"Structure of blood coagulation factor VIII in complex with an anti-C2 domain non-classical, pathogenic antibody inhibitor","volume":"12","author":"Ronayne","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"2022053115234683600_B103","doi-asserted-by":"crossref","first-page":"E2382","DOI":"10.1002\/humu.22247","article-title":"The CDC Hemophilia A Mutation Project (CHAMP) mutation list: a new online resource","volume":"34","author":"Payne","year":"2013","journal-title":"Hum Mutat."},{"issue":"2","key":"2022053115234683600_B104","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1098-1004(1999)13:2<160::AID-HUMU9>3.0.CO;2-C","article-title":"Identification of twenty-one new mutations in the factor IX gene by SSCP analysis","volume":"13","author":"Montejo","year":"1999","journal-title":"Hum Mutat."},{"issue":"28","key":"2022053115234683600_B105","doi-asserted-by":"crossref","first-page":"25393","DOI":"10.1074\/jbc.M105432200","article-title":"Identification of functionally important residues of the epidermal growth factor-2 domain of factor IX by alanine-scanning mutagenesis. Residues Asn(89)-Gly(93) are critical for binding factor VIIIa","volume":"277","author":"Chang","year":"2002","journal-title":"J Biol Chem."},{"issue":"18","key":"2022053115234683600_B106","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1093\/nar\/19.18.4821","article-title":"Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene","volume":"19","author":"Tuddenham","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"2022053115234683600_B107","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1073\/pnas.89.11.4933","article-title":"Hemophilia A due to mutations that create new N-glycosylation sites","volume":"89","author":"Aly","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"2022053115234683600_B108","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/hae.12172","article-title":"Detection of new mutations and molecular pathology of mild and moderate haemophilia A patients from southern Brazil","volume":"19","author":"Rosset","year":"2013","journal-title":"Haemophilia."},{"issue":"8","key":"2022053115234683600_B109","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1538-7836.2010.03913.x","article-title":"Generation of a novel factor IX with augmented clotting activities in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Lin","year":"2010","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022053115234683600_B110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1160\/TH13-02-0154","article-title":"Incorporation of the factor IX Padua mutation into FIX-Triple improves clotting activity in\u00a0vitro and in\u00a0vivo","volume":"110","author":"Kao","year":"2013","journal-title":"Thromb Haemost."},{"issue":"21","key":"2022053115234683600_B111","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1182\/blood.2020006005","article-title":"Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua","volume":"137","author":"Nair","year":"2021","journal-title":"Blood."},{"issue":"March","key":"2022053115234683600_B112","first-page":"184","article-title":"Protein-engineered coagulation factors for hemophilia gene therapy","volume":"12","author":"Samelson-Jones","year":"2018","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"37","key":"2022053115234683600_B113","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1021\/bi025785v","article-title":"Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface","volume":"41","author":"Ahmad","year":"2002","journal-title":"Biochemistry."},{"issue":"3","key":"2022053115234683600_B114","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/bj2360861","article-title":"The interaction of bovine factor IX, its activation intermediate, factor IX \u03b1, and its activation products, factor IXa \u03b1 and factor IXa \u03b2, with acidic phospholipid vesicles of various compositions","volume":"236","author":"Beals","year":"1986","journal-title":"Biochem J."},{"issue":"3","key":"2022053115234683600_B115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/bj2230599","article-title":"Binding of human blood-coagulation Factors IXa and X to phospholipid membranes","volume":"223","author":"Mertens","year":"1984","journal-title":"Biochem J."},{"issue":"20","key":"2022053115234683600_B116","doi-asserted-by":"crossref","first-page":"12089","DOI":"10.1074\/jbc.273.20.12089","article-title":"Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity","volume":"273","author":"Chang","year":"1998","journal-title":"J Biol Chem."},{"issue":"10","key":"2022053115234683600_B117","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2015-01-620245","article-title":"Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine","volume":"126","author":"Gilbert","year":"2015","journal-title":"Blood."},{"issue":"Pt 3","key":"2022053115234683600_B118","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1042\/BJ20031748","article-title":"Kinetics of factor X activation by the membrane-bound complex of factor IXa and factor VIIIa","volume":"381","author":"Panteleev","year":"2004","journal-title":"Biochem J."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3240\/1899302\/advancesadv2021005874.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3240\/1899302\/advancesadv2021005874.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T11:25:50Z","timestamp":1653996350000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/11\/3240\/484305\/SAXS-analysis-of-the-intrinsic-tenase-complex"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":118,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,6,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005874","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.09.451823","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}